Supreme Court Rules Naturally Occurring Human DNA Not Elligible for Patenting

June 18, 2013

Retrieved from: In a landmark decision, the U.S Supreme Court ruled last Thursday that companies cannot patent human DNA. Contending this case is Myriad Genetics, who claimed that because they had discovered and isolated two human DNA genes, named BRCA1 and BRCA2, they could put a patent on their use. The court found that…

Read More